A short-term preliminary evaluation of ventral hernia repair using a new prosthetic mesh

摘要

BACKGROUND: Syneco® (W.L. Gore and Associates, Flagstaff, AZ) is a new permanent synthetic mesh made of a combination of an absorbable synthetic component and a permanent synthetic component that can be used intraperitoneally or within the abdominal wall layers. Currently, there are little data on outcomes related to this mesh product. AIMS AND OBJECTIVES: The purpose of this project is to review our medical center's outcomes using Synecor® mesh in ventral hernia repair. MATERIALS AND METHODS: We retrospectively reviewed all patients at our single medical center undergoing ventral hernia repair using Synecor® mesh included in the Americas Hernia Society Quality Collaborative (AHSQC) database from April 2016 through September 2019. Demographic, perioperative, and short-term outcomes (surgical site infection [SSI], surgical site occurrence [SSO], surgical site occurrence requiring procedural intervention [SSOPI]) were reviewed, and descriptive statistics were calculated. RESULTS: Forty-eight patients who underwent ventral hernia repairs using Synecor® mesh met study inclusion criteria. The average age of our patient population was 59 years (range: 29-78) with 50% female and 85% Caucasian. Ninety-six percent of cases were classed as clean cases. Comorbidities were present in 73% of patients. Open repairs were completed in 56% of cases and included retrorectus repair in 67% and transversus abdominis muscle release (TAR) in 30% of open cases. Repairs were laparoscopic in 27% of cases and robotic in 17%, with 85% having closure of the defect during repair. At 30 days follow-up, the rate of SSI was 8%, SSO 17%, and SSOPI 13%. There was an overall complication rate of 29%, a hernia recurrence rate of 4%, and an average follow-up of 97 days (range: 0 days to 1 year). CONCLUSION: Synecor® mesh is a new synthetic mesh that can be used for ventral hernia repair in an open, laparoscopic, or robotic approach. Short-term, preliminary results appear favorable; however, more study is needed to fully evaluate this new mesh prosthetic.